Alana D. Carpenter,^1,2,* Yaoxiang Li,^3,* Stephen Y. Wise,^1,2 Oluseyi O. Fatanmi,^1,2 Sarah A. Petrus,^1,2 Christine M. Fam,⁴ Sharon J. Carlson,⁴ George N. Cox,⁴ Amrita K. Cheema,^3,5 Vijay K. Singh<sup>1,2,**

1</sup>Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814
²Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814
³Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057
⁴Bolder BioTechnology, Boulder, Colorado, 80301
⁵Department of Biochemistry, Molecular and Cellular Biology, Georgetown University Medical Center, Washington, DC 20057

^*These authors contributed equally to this study.
^**Corresponding author: Vijay K. Singh, Ph.D., Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814; email: vijay.singh@usuhs.edu.